<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Human Papillomavirus &#8211; mikrobik.net</title>
	<atom:link href="https://wp.mikrobik.net/tag/human-papillomavirus/feed/" rel="self" type="application/rss+xml" />
	<link>https://wp.mikrobik.net</link>
	<description></description>
	<lastBuildDate>Wed, 25 Jun 2025 11:47:37 +0000</lastBuildDate>
	<language>tr</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.1</generator>
	<item>
		<title>Human Papillomavirus in Cervical Cancer Screening: Important Role as Biomarker</title>
		<link>https://wp.mikrobik.net/human-papillomavirus-in-cervical-cancer-screening-important-role-as-biomarker/</link>
					<comments>https://wp.mikrobik.net/human-papillomavirus-in-cervical-cancer-screening-important-role-as-biomarker/#respond</comments>
		
		<dc:creator><![CDATA[mikrobik]]></dc:creator>
		<pubDate>Mon, 24 Aug 2009 14:03:00 +0000</pubDate>
				<category><![CDATA[Mikrobiyoloji Derlemeleri]]></category>
		<category><![CDATA[Human Papillomavirus]]></category>
		<guid isPermaLink="false"></guid>

					<description><![CDATA[Human Papillomavirus in Cervical Cancer Screening: Important Role as Biomarker Gaëlle A.V. Boulet, Caroline A.J. Horvath, Sarah Berghmans and Johannes Bogers Cancer Epidemiology Biomarkers &#038; Prevention 17, 810, April 1, 2008 Schematic representation...]]></description>
										<content:encoded><![CDATA[<p><strong>Human Papillomavirus in Cervical Cancer Screening: Important Role as Biomarker</strong><br />
Gaëlle A.V. Boulet, Caroline A.J. Horvath, Sarah Berghmans and Johannes Bogers</p>
<p><a href="http://cebp.aacrjournals.org/cgi/reprint/17/4/810" target="_blank" rel="noopener">Cancer Epidemiology Biomarkers &#038; Prevention 17, 810, April 1, 2008</a></p>
<p><img decoding="async" src="http://cebp.aacrjournals.org/content/vol17/issue4/images/medium/810fig01c.gif" alt="" style="max-width:100%;height:auto;" /></p>
<p>Schematic representation of the HPV genome, highlighting the regions important in PCR-based HPV analysis. L1 region, consensus PCRs, such as SPF, GP5+/6+, and MY09/11, target different conserved regions of the HPV L1 gene, amplifying several genital HPV types in one reaction. Amplicons can be analyzed to discriminate between HPV types by hybridization with type-specific probes or DNA sequencing. E6/E7 region, type-specific PCR assays target specific sequences of viral early genes, usually E6 and E7, and exclusively amplify a single HPV genotype. Application of HPV type–specific PCRs allows immediate discrimination between different HPV types. Quantitative PCR allows simultaneous assessment of HPV presence, genotype, and viral load. E1/E2 region, quantification of the E2 gene allows determination of the HPV integration status.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://wp.mikrobik.net/human-papillomavirus-in-cervical-cancer-screening-important-role-as-biomarker/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
	</channel>
</rss>
